(ALK-B) ALK-Abelló - Performance 14.7% in 12m
Compare ALK-B with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
26.01%
#23 in Group
Rel. Strength
73.47%
#2124 in Universe
Total Return 12m
14.69%
#39 in Group
Total Return 5y
70.64%
#24 in Group
P/E 38.2
77th Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -0.30%
81th Percentile in Group
12m Total Return: ALK-B (14.7%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: ALK-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALK-B
Total Return (including Dividends) | ALK-B | XBI | S&P 500 |
---|---|---|---|
1 Month | 3.94% | -10.94% | -6.73% |
3 Months | -5.02% | -14.92% | -11.93% |
12 Months | 14.69% | -6.46% | 7.24% |
5 Years | 70.64% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | ALK-B | XBI | S&P 500 |
1 Month | 36.9% | -52.8% | -63.5% |
3 Months | -74.9% | -92.8% | -90.3% |
12 Months | -5.50% | -32.4% | 60.6% |
5 Years | 25.7% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #40 | 16.7% | 11.5% |
3 Month | #51 | 11.6% | 7.84% |
12 Month | #40 | 22.6% | 6.95% |
5 Years | #24 | 111% | -14.9% |
FAQs
Does ALK-B ALK-Abelló outperforms the market?
Yes,
over the last 12 months ALK-B made 14.69%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months ALK-B made -5.02%, while XBI made -14.92%.
Over the last 3 months ALK-B made -5.02%, while XBI made -14.92%.
Performance Comparison ALK-B vs Indeces and Sectors
ALK-B vs. Indices ALK-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -2.53% | 10.7% | -2.73% | 7.45% |
US NASDAQ 100 | QQQ | -3.01% | 11.3% | -2.87% | 7.10% |
US Dow Jones Industrial 30 | DIA | -0.50% | 10.9% | -3.35% | 10.2% |
German DAX 40 | DAX | -3.75% | 7.88% | -22.6% | -5.64% |
Shanghai Shenzhen CSI 300 | CSI 300 | -1.96% | 7.33% | -3.88% | 5.48% |
Hongkong Hang Seng | HSI | -5.20% | 7.66% | -7.27% | -2.09% |
India NIFTY 50 | INDA | -4.68% | 1.91% | -6.08% | 11.7% |
Brasil Bovespa | EWZ | -6.80% | 3.48% | -7.78% | 23.4% |
ALK-B vs. Sectors ALK-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -3.24% | 10.8% | -11.9% | -0.38% |
Consumer Discretionary | XLY | -3.97% | 10.8% | -8.03% | 3.40% |
Consumer Staples | XLP | -2.68% | 0.96% | -10.7% | 3.36% |
Energy | XLE | -2.60% | 16.4% | -1.43% | 27.4% |
Financial | XLF | -3.23% | 8.79% | -11.6% | -3.14% |
Health Care | XLV | -0.26% | 11.7% | -0.51% | 17.1% |
Industrial | XLI | -1.93% | 9.97% | -2.56% | 10.6% |
Materials | XLB | -2.27% | 9.79% | 4.53% | 20.6% |
Real Estate | XLRE | -2.30% | 7.17% | -2.38% | -0.04% |
Technology | XLK | -2.80% | 12.9% | 3.51% | 13.5% |
Utilities | XLU | -2.42% | 3.74% | -6.36% | -6.99% |
Aerospace & Defense | XAR | -1.08% | 7.12% | -12.1% | -7.18% |
Biotech | XBI | -5.95% | 14.9% | 8.67% | 21.2% |
Homebuilder | XHB | -4.06% | 12.1% | 12.0% | 25.2% |
Retail | XRT | -4.40% | 9.33% | 0.71% | 21.0% |